The methylation of specific genes, including VASH2, CHFR, GRID2IP, CCNJ, SEPT9, and F12, is considered a biomarker for the onset of hepatocellular carcinoma (HCC) [302]. Here, VASH2 is linked to hepatocellular carcinoma.